Pharmaids Pharmaceuticals Ltd — Others, 14-07-2025: AGM/EGM

Pharmaids Pharmaceuticals seeks shareholder approval via postal ballot for two key business updates. First, the company plans to continue related party transactions with Koye Lifesciences Private Limited, totaling up to 20 Cr for FY26, covering operational and financial services crucial for ongoing business. Second, it intends to divest its entire 66.50% partnership stake in Anugraha Chemicals, a material subsidiary, for an aggregate consideration of 10.50 Cr to an existing partner. This strategic divestment aims to streamline operations and will provide capital for general corporate purposes, including debt reduction and new growth opportunities.